|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000089057 |
Summary for SLC23A2 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000089057 | Gene symbol | SLC23A2 |
| Gene name | solute carrier family 23 member 2 | |
| HGNC | 10973 | |
| Entrez ID | 9962 | |
| Gene type | protein_coding | |
| Synonyms | SLC23A2|SVCT2|KIAA0238|YSPL2 | |
| UniProtAcc | Q9UGH3 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for SLC23A2 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| SLC23A2 | 2.43e+03 | -1.78e+00 | 2.83e-01 | -6.29e+00 | 3.22e-10 | 5.03e-09 | CHOL |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for SLC23A2 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for SLC23A2 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| HNSC | cg12821724 | chr20:5009674 | CGI:chr20:5000956-5001744 | promoter,gene body | 6.92e-01 | 8.18e-01 | -2.83e+00 | 4.60e-03 | 6.63e-03 | -1.26e-01 |
| BLCA | cg25554205 | chr20:5010748 | CGI:chr20:5000956-5001744 | promoter | 6.40e-01 | 8.64e-01 | -2.70e+00 | 7.03e-03 | 1.07e-02 | -2.24e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Top |
Exon skipping events with PSI in TCGA for SLC23A2 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for SLC23A2 |
| ∗Please access CAeditome for RNA editing annotation. |
Landscape of RNA editing events across multiple cancer types. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| KIRC | SLC23A2-004 | chr20_4865448_- | 7.70e-01 | 9.26e-01 | -2.35e+00 | 1.85e-02 | 4.41e-02 | -1.56e-01 |
| LAML | SLC23A2-004 | chr20_4865423_- | 4.30e-01 | 5.83e-01 | -2.17e+00 | 2.99e-02 | 4.94e-02 | -1.52e-01 |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for SLC23A2 |
TFs related to SLC23A2.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| CHOL | NKX3-1 | SLC23A2 | 4.07e+00 | 9.84e-01 | 2.98e+00 | 6.17e-03 | Male-biased |
| CHOL | ZFP82 | SLC23A2 | 3.82e+00 | 9.82e-01 | 2.46e+00 | 1.92e-03 | Male-biased |
| CHOL | ZNF334 | SLC23A2 | 4.07e+00 | 9.90e-01 | 2.38e+00 | 4.32e-04 | Male-biased |
| CHOL | ZNF879 | SLC23A2 | 4.12e+00 | 9.91e-01 | 2.36e+00 | 3.23e-04 | Male-biased |
| PAAD | ZNF334 | SLC23A2 | 4.00e+00 | 9.80e-01 | 3.04e+00 | 5.01e-03 | Male-biased |
| SARC | MBD2 | SLC23A2 | 3.07e+00 | 2.23e-03 | 3.98e+00 | 9.83e-01 | Female-biased |
| SARC | ZNF311 | SLC23A2 | 2.93e+00 | 1.43e-03 | 3.93e+00 | 9.82e-01 | Female-biased |
| SARC | ZNF334 | SLC23A2 | 3.95e+00 | 9.80e-01 | 3.15e+00 | 2.32e-03 | Male-biased |
| SARC | ZNF460 | SLC23A2 | 2.97e+00 | 7.38e-04 | 4.09e+00 | 9.87e-01 | Female-biased |
| SARC | ZNF611 | SLC23A2 | 2.87e+00 | 7.78e-04 | 3.97e+00 | 9.84e-01 | Female-biased |
SLC23A2 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for SLC23A2 |
RBPs related to ES in SLC23A2.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| KICH | BRUNOL6 | exon_skip_354663 | 8.89e+00 | 9.92e-01 | 8.48e+00 | 3.64e-03 | Male-biased |
| KICH | RBM46 | exon_skip_354659 | 7.61e+00 | 4.48e-03 | 8.00e+00 | 9.87e-01 | Female-biased |
| SKCM | BRUNOL6 | exon_skip_354663 | 8.94e+00 | 9.82e-01 | 8.62e+00 | 1.34e-02 | Male-biased |
SLC23A2 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs1022791 | chr20:10750123:T:A | - | 0.213945282920911 | 0.0299142697898357 | READ | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs6037679 | chr20:3860737:C:T | - | 0.320191783216498 | 0.00894598029724905 | READ | Male-baised eQTL |
| rs6133068 | chr20:3861142:G:A | - | 0.320191783216498 | 0.00894598029724905 | READ | Male-baised eQTL |
| rs11907538 | chr20:14709539:C:T | - | 0.0729701165927688 | 0.00494417444674281 | KIRP | Male-baised eQTL |
| rs6135233 | chr20:14704701:G:A | - | 0.069321526542309 | 0.0127572862833839 | KIRP | Male-baised eQTL |
| rs80297567 | chr20:1721813:G:A | - | 0.121773130594285 | 0.0324255165487459 | LIHC | Male-baised eQTL |
| rs6135787 | chr20:1724222:G:A | - | 0.121773130594285 | 0.0324255165487459 | LIHC | Male-baised eQTL |
| rs12480056 | chr20:1728277:C:T | - | 0.121773130594285 | 0.0324255165487459 | LIHC | Male-baised eQTL |
| rs6040409 | chr20:11182401:T:C | - | 0.0901066865683032 | 0.0368554882688301 | LIHC | Male-baised eQTL |
| rs6134023 | chr20:10760527:A:T | - | 0.0572135897874588 | 0.00481305121478616 | BLCA | Male-baised eQTL |
| rs1392631 | chr20:6738130:G:C | - | 0.0608032761086009 | 0.0313446003098895 | BLCA | Male-baised eQTL |
| rs6133777 | chr20:10015302:T:G | - | 0.0454729510258249 | 0.0349893598994027 | BLCA | Male-baised eQTL |
| rs6039652 | chr20:10015509:C:G | - | 0.0447490199659156 | 0.035656617590687 | BLCA | Male-baised eQTL |
| rs8124570 | chr20:12292200:C:T | - | 0.0850066079351462 | 0.0379505065371595 | BLCA | Male-baised eQTL |
| rs6136826 | chr20:2045422:C:T | - | 0.0499176336620625 | 0.0479393197328377 | BLCA | Male-baised eQTL |
| rs7361701 | chr20:3245089:C:G | - | 0.0887214581329965 | 0.0486059671381331 | BLCA | Male-baised eQTL |
| rs6042407 | chr20:13876846:C:T | - | 0.145910757615083 | 0.00994711569674426 | COAD | Male-baised eQTL |
| rs36110400 | chr20:13897960:A:C | - | 0.14853443894133 | 0.0127965285243794 | COAD | Male-baised eQTL |
| rs13043535 | chr20:9034227:T:C | - | -0.0619205455820505 | 0.016693740495575 | COAD | Male-baised eQTL |
| rs6042410 | chr20:13882977:C:T | - | 0.142749916679614 | 0.0174826034470537 | COAD | Male-baised eQTL |
| rs6108320 | chr20:9652356:T:C | - | 0.0684012844085937 | 0.0179444011456017 | COAD | Male-baised eQTL |
| rs62207750 | chr20:13987336:T:C | - | 0.14273967760787 | 0.0200612871249542 | COAD | Male-baised eQTL |
| rs17226852 | chr20:13993114:T:C | - | 0.14273967760787 | 0.0200612871249542 | COAD | Male-baised eQTL |
| rs34529022 | chr20:13888569:A:G | - | 0.141814453668623 | 0.0217567940720318 | COAD | Male-baised eQTL |
| rs13043492 | chr20:13883694:C:T | - | 0.141495418353815 | 0.0221377491059533 | COAD | Male-baised eQTL |
| rs16994193 | chr20:13884447:C:T | - | 0.141495418353815 | 0.0221377491059533 | COAD | Male-baised eQTL |
| rs16994196 | chr20:13884994:C:A | - | 0.141495418353815 | 0.0221377491059533 | COAD | Male-baised eQTL |
| rs6042419 | chr20:13893787:C:T | - | 0.141495418353815 | 0.0221377491059533 | COAD | Male-baised eQTL |
| rs6056344 | chr20:9026567:G:C | - | -0.0616634733476762 | 0.0228403740088209 | COAD | Male-baised eQTL |
| rs6042409 | chr20:13881255:G:T | - | 0.141174436304488 | 0.0229025907513884 | COAD | Male-baised eQTL |
| rs11905248 | chr20:13886519:C:A | - | 0.140902254259475 | 0.0232100910843896 | COAD | Male-baised eQTL |
| rs6033846 | chr20:13878949:T:C | - | 0.140860021179168 | 0.0232781716283295 | COAD | Male-baised eQTL |
| rs6042416 | chr20:13890934:A:G | - | 0.140860021179168 | 0.0232781716283295 | COAD | Male-baised eQTL |
| rs13036689 | chr20:13894368:T:C | - | 0.140860021179168 | 0.0232781716283295 | COAD | Male-baised eQTL |
| rs17226845 | chr20:13977540:A:G | - | 0.140022171054255 | 0.0245321423746397 | COAD | Male-baised eQTL |
| rs8184236 | chr20:3058469:G:A | - | 0.0640061033122422 | 0.0279962796331183 | COAD | Male-baised eQTL |
| rs7264448 | chr20:3058711:A:C | - | 0.0640061033122422 | 0.0279962796331183 | COAD | Male-baised eQTL |
| rs7271085 | chr20:3058713:G:A | - | 0.0640061033122422 | 0.0279962796331183 | COAD | Male-baised eQTL |
| rs77554065 | chr20:13892308:C:G | - | 0.133056688673094 | 0.0282711675857795 | COAD | Male-baised eQTL |
| rs6135003 | chr20:13892309:A:G | - | 0.133056688673094 | 0.0282711675857795 | COAD | Male-baised eQTL |
| rs6033848 | chr20:13892410:G:A | - | 0.133056688673094 | 0.0282711675857795 | COAD | Male-baised eQTL |
| rs6042418 | chr20:13892926:T:C | - | 0.133056688673094 | 0.0282711675857795 | COAD | Male-baised eQTL |
| rs11906790 | chr20:13895276:C:T | - | 0.139997850822528 | 0.0284202479435119 | COAD | Male-baised eQTL |
| rs583688 | chr20:3639124:T:C | - | 0.0626800102909364 | 0.0294777017090902 | COAD | Male-baised eQTL |
| rs6042423 | chr20:13896750:A:G | - | 0.139362453647881 | 0.0297781925319745 | COAD | Male-baised eQTL |
| rs2876148 | chr20:9041660:G:C | - | -0.0610504541586528 | 0.0299991377214633 | COAD | Male-baised eQTL |
| rs2261282 | chr20:14032218:G:A | - | -0.136224327259628 | 0.0321473691562848 | COAD | Male-baised eQTL |
| rs2259700 | chr20:14045464:T:C | - | -0.136224327259628 | 0.0321473691562848 | COAD | Male-baised eQTL |
| rs56344714 | chr20:3055835:T:C | - | 0.0645875140164969 | 0.0322166750068968 | COAD | Male-baised eQTL |
| rs59431904 | chr20:13896011:G:A | - | 0.131427302342178 | 0.035730488316639 | COAD | Male-baised eQTL |
| rs35992528 | chr20:13897459:C:T | - | 0.131427302342178 | 0.035730488316639 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg08435683 | chr20:4855692 | gene,exon,UTR | -0.471191371625837 | 4.651622340243e-70 | -0.8987362605949134 | 3.529588115693523e-73 | KIRP |
| cg12821724 | chr20:5009674 | gene,promoter | -0.471191371625837 | 4.651622340243e-70 | -0.8987362605949134 | 3.529588115693523e-73 | KIRP |
| cg25554205 | chr20:5010748 | promoter | -0.471191371625837 | 4.651622340243e-70 | -0.8987362605949134 | 3.529588115693523e-73 | KIRP |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of SLC23A2 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000089057 | SLC23A2 | C0008370 | Cholestasis | 1 | CTD_human |